.On the heels of an FDA rejection for its main rival Novo Nordisk, Eli Lilly is actually gaining gro...
.Simply a couple of months after dosing the very first patient in a period 2 trial for recently dete...
.Eli Lilly's look for obesity intendeds has led it to the dark genome. The Big Pharma has actually c...
.Toolbox Biosciences is proceeding up. The tissue therapy provider has added on $325 thousand in amm...
.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...
.Aelis Farma's hopes of securing an easy, positive selection on a $100 million alternative remittanc...
.ProKidney has ceased some of a set of period 3 trials for its tissue treatment for renal illness af...
.Vaxcyte revealed what professionals referred to as "spectacular" stage 1/2 information for its 31-v...
.Recursion has stumbled via a very early examination of its own tech-enabled method to medicine reve...
.Call it a situation of excellent chemical make up: Acepodia, a biotech based on Nobel Champion scie...